FLT3 inhibitors in acute myeloid leukemia

K El-Shami, RM Stone, BD Smith - Expert review of hematology, 2008 - Taylor & Francis
The fms-like tyrosine kinase 3 (FLT3) plays an important role in both normal and malignant
hematopoiesis. Activating mutations in the FLT3 receptor can be detected in approximately …
被引用次数：12 相关文章

FLT3 inhibitors in acute myeloid leukemia.

K el-Shami, RM Stone, BD Smith - Expert Review of Hematology, 2008 - europepmc.org
The fms-like tyrosine kinase 3 (FLT3) plays an important role in both normal and malignant
hematopoiesis. Activating mutations in the FLT3 receptor can be detected in approximately …

FLT3 inhibitors in acute myeloid leukemia

K el-Shami, RM Stone… - Expert review of …, 2008 - pubmed.ncbi.nlm.nih.gov
The fms-like tyrosine kinase 3 (FLT3) plays an important role in both normal and malignant
hematopoiesis. Activating mutations in the FLT3 receptor can be detected in approximately …

FLT3 inhibitors in acute myeloid leukemia

K el-Shami, RM Stone, BD Smith - Expert Review of Hematology, 2008 - go.gale.com
Receptor tyrosine kinases are transmembrane proteins that generally include an
extracellular ligand-binding domain, a membrane-spanning domain and a catalytic …

FLT3 inhibitors in acute myeloid leukemia

K El-Shami, RM Stone… - Expert Review of …, 2008 - search.proquest.com
The fms-like tyrosine kinase 3 (FLT3) plays an important role in both normal and malignant
hematopoiesis. Activating mutations in the FLT3 receptor can be detected in approximately …

FLT3 inhibitors in acute myeloid leukemia

K el-Shami, RM Stone - Expert review of hematology, 2008 - pure.johnshopkins.edu
The fms-like tyrosine kinase 3 (FLT3) plays an important role in both normal and malignant
hematopoiesis. Activating mutations in the FLT3 receptor can be detected in approximately …